title: ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.
abstract: Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood and can profoundly affect the academic achievement, well-being, and social interactions of children; the American Academy of Pediatrics first published clinical recommendations for the diagnosis and evaluation of ADHD in children in 2000; recommendations for treatment followed in 2001.
authors: Mark
authors: M
authors: Wolraich
authors: Lawrence
authors: L
authors: Brown
authors: Ronald T
authors: RT
authors: Brown
authors: George
authors: G
authors: DuPaul
authors: Marian
authors: M
authors: Earls
authors: Heidi M
authors: HM
authors: Feldman
authors: Theodore G
authors: TG
authors: Ganiats
authors: Beth
authors: B
authors: Kaplanek
authors: Bruce
authors: B
authors: Meyer
authors: James
authors: J
authors: Perrin
authors: Karen
authors: K
authors: Pierce
authors: Michael
authors: M
authors: Reiff
authors: Martin T
authors: MT
authors: Stein
authors: Susanna
authors: S
authors: Visser
mesh_terms: D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D015994:Incidence; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D012955:Societies, Medical; D016896:Treatment Outcome; D014481:United States
chemical_list: D000697:Central Nervous System Stimulants